Sign In

Key Populations.

HIV Question Bank

HIV-2 InfectionQuestion 9/10

Questions in Topic

A 46-year-old woman from Ivory Coast with HIV-2 is seen in clinic for a follow-up visit after having virologic failure with tenofovir DF-emtricitabine and lopinavir-ritonavir. The decision is made to modify the antiretroviral regimen. Drug resistance testing for HIV-2 is not available.

Which one of the following is TRUE regarding treatment of HIV-2 with the integrase strand transfer inhibitors (INSTIs) bictegravir, cabotegravir, dolutegravir, elvitegravir, and raltegravir?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
February 2nd, 2025

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.